← All organizations

Black Diamond Therapeutics, Inc.

For profitWebsite ↗

Also known as: Black Diamond Therapeutics | Black Diamond Therapeutics, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Apr 18, 2023

Timeline

2010s

Jun 1, 2017
Black Diamond Therapeutics, Inc.— Founded

Drugs by trial phase (3 distinct, 3 trials)

Phase 2 (1 own, 0 via acquisition)

Tuxobertinib

Phase 1 (2 own, 0 via acquisition)

Recent trials (5)

NCT05786924Lead sponsorPhase 1Apr 18, 2023
NCT05256290Lead sponsorPhase 1Mar 31, 2022
NCT05256290Study directorPhase 1Mar 31, 2022
NCT04209465Lead sponsorPhase 1/Phase 2Dec 19, 2019
NCT04209465Study directorPhase 1/Phase 2Dec 19, 2019

Details

Founded: Cambridge, MA, US Jun 1, 2017
Last known activity: Apr 18, 2023